We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Janus Henderson Global Life Sciences Class H2 - Accumulation (USD)

Sell:$35.62 Buy:$35.62 Change: $0.37 (1.05%)
Prices as at 1 November 2024
Sell:$35.62
Buy:$35.62
Change: $0.37 (1.05%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 1 November 2024
Sell:$35.62
Buy:$35.62
Change: $0.37 (1.05%)
Prices as at 1 November 2024
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Charges and Savings

Initial charges
Initial charge: 0.00%
Initial saving from HL: 0.00%
Net initial charge: 0.00%
HL dealing charge: Free
Annual charges
Performance fee: No  
Ongoing charge (OCF/TER): 0.86%
Ongoing saving from HL: 0.00%
Net ongoing charge: 0.86%
There are other unit types of this fund available:
Class H2 - Accumulation (GBP) (Net ongoing charge 0.86%)

In some cases the ongoing savings are provided by our loyalty bonus. Loyalty bonuses are tax-free in an ISA or SIPP. However, they may be subject to tax in a Fund & Share Account which would, in effect, reduce their value and increase the net ongoing charge.


Other Information

Unit type: Unbundled
Manager:
Andy Acker
Fund launch date: 31 March 2000
Sector: Unclassified
Fund size: £4,339 million
Number of holdings: 108
Fund type: OEIC
Accumulation/income: Accumulation
Dealing frequency: Daily
Valuation point: 16:00
Trustee: J.P. Morgan Bank (Ireland) plc
Minimum investment: £100.00
Available in a regular savings plan: Yes
Minimum regular savings value: £25.00

Ready to invest?

To invest in , you'll need to have an account. Try our handy filter to explore the different options.

Compare accounts

Ready to take your first step?

To invest in , you'll need to open an account. Try our handy filter and find out which suits you best.

Compare accounts

Performance

01/11/19 to 01/11/20 01/11/20 to 01/11/21 01/11/21 to 01/11/22 01/11/22 to 01/11/23 01/11/23 to 01/11/24
Annual return 20.48% 18.84% 8.20% -7.26% 21.50%

Please remember past performance is not a guide to future returns. Where no data is shown, figures are not available. This information is provided to help you choose your own investments, remember they can fall as well as rise in value so you may not get back the original amount invested.

View fund chart

Our view on this fund

The Wealth Shortlist features funds our analysts believe have the potential to outperform their peers over the long term. If a fund is not on the Shortlist, this is not a recommendation to sell; however, if you are thinking of adding to your investments, we believe the Wealth Shortlist is a good place to start. View funds on the Wealth Shortlist »

Fund Objective

We take a global approach to identify high-quality or improving businesses in the life sciences sector that are trading at a discount to our estimate of intrinsic value. We believe the rapidly growing global healthcare sector offers fertile opportunities for differentiated research. We believe what sets us apart is the quality of our team, the depth of our research, and our commitment to delivering superior, long-term results for our clients.

Income Details

Income paid: n/a
Type of payment: No income
Ex-dividend date: 15 April 2025
Payment date: 20 April 20254

This data is provided by Broadridge. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision. All yields are variable and not guaranteed. There is currently no yield information available for this fund.

Security Weight
ELI LILLY AND COMPANY 8.93%
UNITEDHEALTH GROUP INCORPORATED 6.75%
NOVO NORDISK A/S 5.35%
ASTRAZENECA 4.03%
ABBVIE 3.63%
AMGEN 3.21%
MERCK & CO INC(NEW) 2.80%
SANOFI 2.64%
BOSTON SCIENTIFIC CORPORATION 2.46%
NOVARTIS AG 2.35%
Sector Weight
Pharmaceuticals & Biotechnology 64.73%
Medical Equipment & Services 20.77%
Health Care Providers 11.55%
Personal Care, Drug & Grocery Stores 1.48%
Non-Classified 1.23%
Cash and Equiv. 0.24%
Country Weight
United States 75.39%
Denmark 6.52%
United Kingdom 4.39%
Switzerland 3.62%
France 2.64%
Ireland 2.46%
Netherlands 1.82%
Non-Classified 1.23%
Japan 0.70%
Germany 0.61%

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by Morningstar, correct as at 1 November 2024. Data provided by Broadridge, correct as at 31 August 2024.

Broadridge
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account

4 If you elect to receive the income from an ISA or a Fund & Share Account, we will collect any dividends for you and then pay them directly into your bank account within the first 10 working days of the following month.